Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Stoeltzing

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Transplantation|March 14, 2007
Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailabilityGudrun E Koehl, Ferdinand Wagner, Oliver Stoeltzing, et al.
Annals of Surgical Oncology|August 6, 2003
Angiogenesis and antiangiogenic therapy of colon cancer liver metastasisOliver Stoeltzing, Wenbiao Liu, Niels Reinmuth, et al.
Seminars in Cancer Biology|May 25, 2002
The role of the microenvironment and intercellular cross-talk in tumor angiogenesisYoung D Jung, Syed A Ahmad, Wenbiao Liu, et al.
Langenbeck'S Archives of Surgery|February 26, 2008
Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental modelSven Arke Lang, Isabel Brecht, Christian Moser, et al.
The Journal of Clinical Investigation|July 21, 2007
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte contentMarya F McCarty, Ray J Somcio, Oliver Stoeltzing, et al.
Anticancer Research|July 4, 2012
Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancerChristian Moser, Sven A Lang, Christina Hackl, et al.
Oncology (Williston Park, N.Y.)|May 17, 2002
Angiopoietins and their role in colon cancer angiogenesisLee M Ellis, Syed Ahmad, Fan Fan, et al.
International Journal of Oncology|January 23, 2013
EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cellsJung Sun Park, Pham Ngoc Khoi, Young Eun Joo, et al.
Cytokine|November 18, 2005
Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGFWenbiao Liu, Alexander A Parikh, Oliver Stoeltzing, et al.
Seminars in Oncology|July 26, 2002
Antiangiogenic therapy targeting factors that enhance endothelial cell survivalWenbiao Liu, Niels Reinmuth, Oliver Stoeltzing, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Transplantation|March 14, 2007
Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailabilityGudrun E Koehl, Ferdinand Wagner, Oliver Stoeltzing, et al.
Annals of Surgical Oncology|August 6, 2003
Angiogenesis and antiangiogenic therapy of colon cancer liver metastasisOliver Stoeltzing, Wenbiao Liu, Niels Reinmuth, et al.
Seminars in Cancer Biology|May 25, 2002
The role of the microenvironment and intercellular cross-talk in tumor angiogenesisYoung D Jung, Syed A Ahmad, Wenbiao Liu, et al.
Langenbeck'S Archives of Surgery|February 26, 2008
Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental modelSven Arke Lang, Isabel Brecht, Christian Moser, et al.
The Journal of Clinical Investigation|July 21, 2007
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte contentMarya F McCarty, Ray J Somcio, Oliver Stoeltzing, et al.
Anticancer Research|July 4, 2012
Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancerChristian Moser, Sven A Lang, Christina Hackl, et al.
Oncology (Williston Park, N.Y.)|May 17, 2002
Angiopoietins and their role in colon cancer angiogenesisLee M Ellis, Syed Ahmad, Fan Fan, et al.
International Journal of Oncology|January 23, 2013
EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cellsJung Sun Park, Pham Ngoc Khoi, Young Eun Joo, et al.
Cytokine|November 18, 2005
Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGFWenbiao Liu, Alexander A Parikh, Oliver Stoeltzing, et al.
Seminars in Oncology|July 26, 2002
Antiangiogenic therapy targeting factors that enhance endothelial cell survivalWenbiao Liu, Niels Reinmuth, Oliver Stoeltzing, et al.
Pageof 6